Orally administered corticosteroid compositions
US12290598B2 · kind B2 · utility
0Cited by
54References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 5, 2022 |
| Grant date | May 6, 2025 |
| Priority date | — |
| Expiry date | Jul 29, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.